Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · IEX Real-Time Price · USD

5.75

-0.03 (-0.52%)

At close: Jul 19, 2024, 4:00 PM

5.67

-0.08 (-1.39%)

Pre-market: Jul 20, 2024, 9:27 AM EDT

BDTX Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Net Income	-79.79	-82.44	-91.17	-125.6	-67.25	-35.26	Upgrade
Depreciation & Amortization	0.4	0.44	0.51	0.21	0.05	0.05	Upgrade
Share-Based Compensation	8.65	9.6	12.2	14.04	7.77	3.64	Upgrade
Other Operating Activities	2.86	5.68	-6.62	11.21	7.29	6.89	Upgrade
Operating Cash Flow	-67.89	-66.72	-85.08	-100.15	-52.15	-24.67	Upgrade
Capital Expenditures	0.06	0.06	-0.18	-2.71	-0.14	-0.02	Upgrade
Change in Investments	-22.26	16.28	53.55	133.32	-281.55	0	Upgrade
Investing Cash Flow	-22.19	16.35	53.37	130.61	-281.69	-0.02	Upgrade
Share Issuance / Repurchase	76.01	71.93	0.18	0.73	214.94	0	Upgrade
Other Financing Activities	-	-	-	-	-	127.76	Upgrade
Financing Cash Flow	76.01	71.93	0.18	0.73	214.94	127.76	Upgrade
Net Cash Flow	-14.07	21.56	-31.54	31.19	-118.89	103.06	Upgrade
Free Cash Flow	-67.82	-66.66	-85.27	-102.86	-52.29	-24.7	Upgrade
Free Cash Flow Per Share	-1.31	-1.52	-2.35	-2.84	-1.59	-11.90	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).